Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study

被引：0
|
作者：
Rieke Alten
Xavier Mariette
Hanns-Martin Lorenz
Hubert Nüßlein
Mauro Galeazzi
Federico Navarro
Melanie Chartier
Julia Heitzmann
Coralie Poncet
Christiane Rauch
Manuela Le Bars
机构：
[1] Schlosspark-Klinik University Medicine Berlin,Department of Internal Medicine, Rheumatology, Clinical Immunology, and Osteology
[2] Université Paris-Sud,Department of Rheumatology
[3] University Hospital,Department of Rheumatology
[4] University of Erlangen-Nuremberg,Department of Internal Medicine and Rheumatology
[5] University of Siena,Department of Medical Sciences, Surgery, and Neuroscience
[6] Hospital Universitario Virgen Macarena,Department of Rheumatology
[7] Bristol-Myers Squibb,Marketed Product Late Stage Operation Department
[8] Excelya,Department of Immunoscience
[9] Docs International,Speciality Development Immunology
[10] Bristol-Myers Squibb,undefined
[11] Bristol-Myers Squibb,undefined
[12] Janssen-Cilag European Medical Affairs Immunology-Gastroenterology,undefined
来源：
Clinical Rheumatology | 2019年 / 38卷
关键词：
Biologic; Efficacy; Predictor; Remission; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1413 / 1424
页数：11
相关论文
共 50 条
  • [1] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
    Alten, Rieke
    Mariette, Xavier
    Lorenz, Hanns-Martin
    Nuesslein, Hubert
    Galeazzi, Mauro
    Navarro, Federico
    Chartier, Melanie
    Heitzmann, Julia
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1413 - 1424
  • [2] Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
    Rieke Alten
    Xavier Mariette
    Hanns-Martin Lorenz
    Hubert Nüßlein
    Mauro Galeazzi
    Federico Navarro
    Melanie Chartier
    Julia Heitzmann
    Coralie Poncet
    Christiane Rauch
    Manuela Le Bars
    [J]. Clinical Rheumatology, 2019, 38 : 1535 - 1535
  • [3] ABATACEPT RETENTION RATES AND PROGNOSTIC FACTORS OF RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS: 2-YEAR RESULTS FROM THE REAL-WORLD ACTION STUDY
    Alten, R.
    Lorenz, H-M.
    Mariette, X.
    Nuesslein, H.
    Galeazzi, M.
    Navarro, F.
    Chartier, M.
    Elbez, Y.
    Rauch, C.
    Le Bars, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 577 - 578
  • [4] Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study
    Peichl, Peter
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Nuesslein, Hubert
    Navarro, Federico
    Elbez, Yedid
    Chartier, Melanie
    Hackl, Roland
    Rauch, Christiane
    Connolly, Sean E.
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2020, 170 (5-6) : 132 - 140
  • [5] Abatacept retention and clinical effectiveness in patients with rheumatoid arthritis in a real-world setting in Taiwan
    Chen, Kun-Hung
    Li, Ko-Jen
    Fang, Yao-Fan
    Hsieh, Song-Chou
    Chen, Ying-Chou
    Lee, Chyou-Shen
    Luo, Shue-Fen
    Cheng, Tien-Tsai
    Tsai, Wen Chan
    Lo, Yu-Chen
    Lan, Joung-Liang
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (07)
  • [6] Abatacept Retention Rates and Prognostic Factors of Retention in Patients with Rheumatoid Arthritis (RA) Treated in Canada: 2-Year Results from a Real-World Observational Study
    Haraoui, Boulos
    Choquette, Denis
    Bessette, Louis
    Khraishi, Majed
    Maoui, Meryem
    Heitzmann, Julia
    Connolly, Sean
    Alten, Rieke
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 980 - 980
  • [7] Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study
    Rieke Alten
    Xavier Mariette
    René-Marc Flipo
    Roberto Caporali
    Maya H. Buch
    Yusuf Patel
    Sara Marsal
    Raimon Sanmartí
    Michael T. Nurmohamed
    Hedley Griffiths
    Peter Peichl
    Bettina Bannert
    Melanie Chartier
    Sean E. Connolly
    Karissa Lozenski
    Christiane Rauch
    [J]. Clinical Rheumatology, 2022, 41 : 2361 - 2373
  • [8] Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study
    Alten, Rieke
    Mariette, Xavier
    Flipo, Rene-Marc
    Caporali, Roberto
    Buch, Maya H.
    Patel, Yusuf
    Marsal, Sara
    Sanmarti, Raimon
    Nurmohamed, Michael T.
    Griffiths, Hedley
    Peichl, Peter
    Bannert, Bettina
    Chartier, Melanie
    Connolly, Sean E.
    Lozenski, Karissa
    Rauch, Christiane
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2361 - 2373
  • [9] PREDICTORS OF RETENTION WITH ABATACEPT IN PATIENTS WHO HAVE FAILED ONE OR MORE BIOLOGIC AGENTS: RESULTS FROM THE INTERNATIONAL, REAL-WORLD ACTION STUDY
    Nuesslein, Hubert
    Alten, Rieke
    Galeazzi, Maurizio
    Lorenz, Hannes M.
    Nurmohamed, Michael T.
    Bensen, William
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. RHEUMATOLOGY, 2014, 53 : 94 - 95
  • [10] Predictors of retention with abatacept in patients who have failed one or more biologic agents: results from the international, real-world ACTION study
    Nuesslein, H.
    Alten, R.
    Galeazzi, M.
    Lorenz, H.
    Boumpas, D.
    Nurmohamed, M.
    Bensen, W.
    Burmester, G.
    Peter, H.
    Rainer, F.
    Pavelka, K.
    Chartier, M.
    Poncet, C.
    Rauch, C.
    LeBars, M.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 108 - 108
12345